The Siberian Scientific Medical Journal / Key word: , иматиниб
CLINICAL MEDICINE
The results of 12 years treatment of patients in late chronic phase of chronic myeloid leukemia by tyrosine kinase inhibitors after failure IFN-α
Lazareva O.V., Turkina A.G., Gusarova G.A., Chelysheva E.Yu., Zakharova E.S., Shukhov O.A., Bykova A.V., Goryacheva S.R., Kolosheinova T.I., Ivanova T.V., Tishchenko I.A., Kulikov S.M.
Tactics of therapy in chronic myeloid leukemia during pregnancy. Clinical case
Chelysheva E.Yu., Turkina A.G., Polushkina E.S., Shmakov R.G.
Long-term results of therapy by dasatinib and features analysis of the pleural effusion course in patients at late chronic phase of chronic myeloid leukemia after imatinib treatment failure
Abdullaev A.O., Chelysheva E.Yu., Turkina A.G., Lazareva O.V., Kuznetsov S.V., Ivanova T.V., Gusarova G.A., Goryacheva S.R., Vorontsova A.V., Vinogradova O.Yu., Bykova A.V., Shukhov O.A.